CNTB: Connect Biopharma Holdings Sotuvga nisbatan narx
Connect Biopharma bioskrining uchun sun'iy intellekt dasturiy ta'minoti va robototexnikani joriy qilmoqda. Sotuvlarga nisbatan narx ko'rsatkichi joriy bozor tendentsiyasini aks ettiradi, bunda 14.10 qiymati haqiqiy raqamni ko'rsatadi. Kompaniya ishlab chiqarish va sinovlarni uchinchi tomon pudratchilariga autsorsing qilish orqali xarajatlarni minimallashtirgan holda, saxiy aksiyalar opsionlari bilan global bioximiklarni jalb qilmoqda. Ushbu yondashuv immun dorilarini ishlab chiqish jarayonida ilmiy jamoaning moslashuvchanligini ta'minlaydi.
Connect Biopharma (CNTB) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Connect Biopharma|CNTB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi connectbiopharm.com|CNTB - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Connect Pharma|CNTB - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Connect Biopharma|Oraliq likvidlik koeffitsiyenti connectbiopharm.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CNTB - Sof daromad|Kutilayotgan sof daromad Connect Biopharma|CNTB - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati connectbiopharm.com|CNTB - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Connect Pharma|CNTB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Connect Biopharma|CNTB - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun sof foydaning yillik dinamikasi connectbiopharm.com|CNTB - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Connect Biopharma
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:CNTB - Connect Biopharma Holdings
Connect Biopharma (CNTB) klinik sinovlarning muvaffaqiyatidan foydalangan holda, og'ir allergiyalarni davolash uchun innovatsion dori vositalarini ishlab chiqmoqda. Bozor kapitalizatsiyasining yillik daromadga nisbati biznes qiymatini uning haqiqiy savdo hajmi bilan nisbatan baholash imkonini beradi. Narxning savdoga nisbatini tahlil qilish orqali investor narxlardagi buzilishlarni va fundamental qiymatdan spekulyativ chetga chiqishlarni aniqlashi mumkin. Ushbu ko'rsatkichning barqarorligi biznes modelining chidamliligini va tibbiyot hamjamiyatining kompaniya aktivlariga bo'lgan ishonchini tasdiqlaydi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA Bio - P/S multiplikatori|Protagonist Corp (PTGX) - Kapitalizatsiyaning daromadga nisbati|Immunovant, Inc. (IMVT) - Narxning daromadga nisbati|Sotuvga nisbatan narx kiniksa.com (KNSA)|Narxning daromadga nisbati Grifols|Kapitalizatsiya va daromad nisbati ADPT (Adaptive Biotech)|Narxning daromadga nisbati Celldex (CLDX)|Aurinia Corp - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BCRX (BioCryst)|veratx.com (VERA) - Sotuvga nisbatan narx|Dianthus Therapeutics, Inc. - P/S multiplikatori|Pharvaris NV (PHVS) - Kapitalizatsiyaning daromadga nisbati|ABCL (AbCellera Biologics Inc) - Kapitalizatsiyaning daromadga nisbati|TRML: Kapitalizatsiyaning sotish hajmiga nisbati|Kapitalizatsiyaning daromadga nisbati PGEN|PHAR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NKTR|Narxning daromadga nisbati UPB (Upstream Bio, Inc.)|P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Narx/daromad koeffitsiyenti Immunome Bio (IMNM)|GOSS - Narxning daromadga nisbati|Sotuvga nisbatan narx kalvista.com|Septerna (SEPN) - Narxning daromadga nisbati|Narxning sotuvga nisbati PVLA (Pieris Pharma)|SVRA (Savara Corp) - P/S multiplikatori|RIGL: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ANAB|P/S multiplikatori astriatx.com (ATXS)|Narxning daromadga nisbati enGene ENGN|Bozor kapitallashuvining daromadga nisbati RAPT|JBIO - Narxning daromadga nisbati|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning daromadga nisbati|KYTX: P/S multiplikatori|tizianalifesciences.com (TLSA) - P/S multiplikatori|CABA (Cabaletta Bio) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Ventyx Biosciences Inc. (VTYX)|Narxning daromadga nisbati Theratechnologies Inc (THTX)|Avalo Therapeutics Inc - Kapitalizatsiya va daromad nisbati|Eledon Pharmaceuticals - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati AGEN (agenusbio.com)|Climb Bio - P/S multiplikatori|ZURA: Narxning daromadga nisbati|aTyr (ATYR) - Narxning daromadga nisbati|Narxning sotuvga nisbati ADAG (Adagene Inc.)|IMA (ImageneBio) - P/S multiplikatori|STTK: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EQ|P/S multiplikatori immunic-therapeutics.com (IMUX)|Narxning daromadga nisbati Atara Bio ATRA|Bozor kapitallashuvining daromadga nisbati IFRX|XFOR - Narxning daromadga nisbati|Adicet Bio (ACET) - Kapitalizatsiyaning daromadga nisbati|CELU: P/S multiplikatori|INmune Bio Inc (INMB) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati BRNS|KZR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori SABS|Narx/daromad koeffitsiyenti akaritx.com|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Kapitalizatsiyaning daromadga nisbati|GOVX - Narxning daromadga nisbati|Edesa Biotech Corp (EDSA) - Kapitalizatsiyaning daromadga nisbati|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|Carisma Therapeutics Inc. (CARM) - P/S multiplikatori|Narxning daromadga nisbati XTL Biopharmaceuticals Ltd.|Kapitalizatsiya va daromad nisbati BOLT (Bolt Bio)|P/S multiplikatori HCWB|APVO - Sotuvga nisbatan narx|P/S multiplikatori AIM (AIM ImmunoTech Inc.)|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI - Narxning daromadga nisbati|Sotuvga nisbatan narx XORTX Therapeutics Inc|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati REVB|Narxning daromadga nisbati Indaptus Therapeutics|Kapitalizatsiya va daromad nisbati SCNI (scinai.com)|P/S multiplikatori CALI|AFMD - Sotuvga nisbatan narx|P/S multiplikatori ALLK (Allakos)|HOOK - Kapitalizatsiyaning daromadga nisbati|IGMS: Kapitalizatsiyaning daromadga nisbati|iteostherapeutics.com - Kapitalizatsiyaning sotish hajmiga nisbati|OCEA (Ocean Biomedical) - Kapitalizatsiyaning daromadga nisbati|TC BioPharm (Holdings) Plc - Bozor kapitallashuvining daromadga nisbati|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
